SUPERNUS PHARMACEUTICALS INC (SUPN) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 566 transactions totaling $184.6M, demonstrating a bearish sentiment with -$18.2M in net insider flow. The most recent transaction on Jan 9, 2026 involved a transaction of 15,000 shares valued at $0.
No significant insider buying has been recorded for SUPN in the recent period.
No significant insider selling has been recorded for SUPN in the recent period.
Based on recent SEC filings, insider sentiment for SUPN is bearish with an Insider Alignment Score of 45/100 and a net flow of -$18.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at SUPERNUS PHARMACEUTICALS INC (SUPN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading SUPN stock, having executed 566 transactions in the past 90 days. The most active insider is Jack A. Khattar (Executive), who has made 145 transactions totaling $45.1M.
Get notified when executives and directors at SUPN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | M. Hudson Frederick | Executive | Option Exercise | 15,000 | $N/A | $0 | |
| Jan 9, 2026 | M. Hudson Frederick | Executive | Option Exercise | 15,000 | $12.98 | $194.7K | |
| Dec 19, 2025 | Mottola Frank | Executive | Option Exercise | 15,000 | $25.30 | $379.5K | |
| Dec 19, 2025 | Mottola Frank | Executive | Option Exercise | 5,000 | $39.40 | $197.0K | |
| Dec 19, 2025 | Mottola Frank | Executive | Sale | 5,000 | $50.22 | $251.1K | |
| Dec 19, 2025 | Mottola Frank | Executive | Sale | 15,000 | $50.47 | $757.0K | Large |
| Dec 18, 2025 | P. Bhatt Padmanabh | Executive | Option Exercise | 1,500 | $N/A | $0 | |
| Dec 18, 2025 | P. Bhatt Padmanabh | Executive | Sale | 710 | $44.44 | $31.6K | |
| Nov 21, 2025 | W. Newhall Charles III | Executive | Option Exercise | 15,000 | $12.98 | $194.7K | |
| Oct 9, 2025 | W. Newhall Charles III | Executive | Sale | 23,800 | $50.73 | $1.2M | Large |
| Oct 9, 2025 | W. Newhall Charles III | Executive | Sale | 1,200 | $51.55 | $61.9K | |
| Oct 9, 2025 | A. Khattar Jack | Executive | Sale | 1,529 | $51.46 | $78.7K | |
| Oct 9, 2025 | A. Khattar Jack | Executive | Sale | 58,371 | $50.55 | $3.0M | Large |
| Oct 9, 2025 | A. Khattar Jack | Executive | Option Exercise | 81,250 | $25.30 | $2.1M | Large |
| Oct 2, 2025 | A. Khattar Jack | Executive | Sale | 1,904 | $48.06 | $91.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 169 | $101.4M | 47.1% |
Purchase(P) | 25 | $83.2M | 38.6% |
Exercise(M) | 158 | $26.9M | 12.5% |
Payment(F) | 29 | $3.4M | 1.6% |
Award(A) | 46 | $625.1K | 0.3% |
Other(J) | 103 | $0 | 0.0% |
Gift(G) | 26 | $0 | 0.0% |
Conversion(C) | 10 | $0 | 0.0% |
Insider activity at SUPERNUS PHARMACEUTICALS INC shows mixed signals across all time. While $83.2M in purchases indicates some executive confidence,$101.4M in sales balances the picture, resulting in a modest net flow of -$18.2M.29 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Jack A. Khattar, has transacted $45.1M during this period.